RxDoctor Payments Data

Armando Martinez, MD

Family Medicine · Merritt Island, FLNPI 1043305949

Payments from drug & device makers

$26,303in general payments, 2019–2025

Across 256 payments — averaging $102.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$4K
  • AstraZeneca$3K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Amgen$1K
  • GSK$999
  • Novo Nordisk$918
  • plus $14K from 52 others

What the payments were for

  • Food & beverage$26,303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,303 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$67,290
Medicare patients
111
Services billed
604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ShingrixVaricella-Zoster Ge/As01b/Pf711$150,241
AbrysvoRsv Vacc, Pref A And Pref B/Pf436$132,455
EliquisApixaban74$63,198
OzempicSemaglutide57$56,453
Dexlansoprazole DrDexlansoprazole59$22,904
Diclofenac Sodium63$22,347
MresviaRsv Vaccine, Pref, Mrna/Pf69$20,242
FarxigaDapagliflozin Propanediol19$15,503
Fluticasone-SalmeterolFluticasone Propion/Salmeterol55$15,392
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen550$9,528
OxycontinOxycodone Hcl12$9,472
Albuterol Sulfate HfaAlbuterol Sulfate219$9,303
Amlodipine-AtorvastatinAmlodipine/Atorvastatin22$6,150
Tresiba Flextouch U-100Insulin Degludec14$6,118
Oxycodone Hcl313$5,635

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerAbrysvo, Eliquis$363$195,653510 claims
GSKShingrix, Arexvy$999$153,481722 claims
Novo NordiskOzempic$918$56,45357 claims
AstraZenecaFarxiga$3,392$15,50319 claims
AbbVieSynthroid$665$1,24723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Merritt Island

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →